CT scans track hip implant movement to predict Long-Term stability
NCT ID NCT07698717
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study tracks 30 people receiving a CATALYSTEM cementless hip implant to measure how much the stem moves (subsides) in the thigh bone over two years. Using specialized CT scans, researchers aim to see if the implant stays firmly in place, which is key for long-term success. Participants must have hip osteoarthritis and need a first-time total hip replacement.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- CATALYSTEM Cementless Primary Hip System
- What this could lead to
- If the implant shows stable positioning, it may support its use for long-lasting hip replacement outcomes.
- What could go wrong
- This is a small, early-stage imaging study, not a test of clinical benefits or risks. Results may not predict real-world performance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patient requires primary unilateral THA for a severely painful and/or disabled joint from osteoarthritis, traumatic arthritis, rheumatoid arthritis, avascular necrosis, or congenital dysplasia. 2. Patients is at least 21 years old at the time of informed consent. 3. Patient is able to read and comprehend the informed patient consent document and willing and able to provide informed patient consent for participation in the study and have authorized the transfer of his/her information for study purposes. 4. Patient is able and willing to return for follow-up as specified by the study protocol. 5. Patient is able and willing to complete the required questionnaires and patient-completed portions of the study protocol. Exclusion Criteria: 1. Patient requires implants other than the planned components or would not be a candidate for allowable components to be used (see 4) in the judgement of the surgeon. 2. Patient is planned to have simultaneous bilateral hip arthroplasty 3. Patient had contralateral hip arthroplasty less than 6 months prior to the day of surgery. 4. Patient is expected to have contralateral hip arthroplasty in the following 6 months at the time of consent into this study. 5. Patient has active local or systemic infection. 6. Patient has amputations in either leg that would impact rehabilitation following surgery. 7. Patient has loss of musculature, neuromuscular compromise or vascular compromise that would impact rehabilitation following surgery. 8. Patient has poor bone quality, such as osteoporosis, where in the surgeon's opinion, there could be considerable migration of the prosthesis, or require additional fixation, or a significant chance of periprosthetic fracture, or the lack of adequate bone to support the implant(s). 9. Patient has Charcot's or Paget's disease. 10. Patient is pregnant or lactating. 11. Patient is bedridden. 12. Patient has participated in a clinical investigation with an investigational product (drug or device) in the last 3 months. 13. Patient is currently involved in any personal injury litigation, medical-legal or worker's compensation claims. 14. Patients is, in the opinion of the surgeon, a drug or alcohol abuser or has psychological disorder(s) that could affect their ability to complete patient-reported questionnaires or be compliant with follow-up requirements. 15. Patient is diagnosed and taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Avascular necrosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Orthopaedic Innovation Centre
Winnipeg, Manitoba, R2K 2M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- Can a simple wash stop the bacteria behind shoulder surgery infections?
- A new ankle? researchers track 400 people with an implant meant to restore movement
- Can a Job-Focused rehab program keep arthritis patients employed?
- Brain waves may reveal how well a sedative blocks surgical pain
- Hip replacement showdown: does the labrum stay or go?